Updated recommendations on the use of meningococcal vaccines
- Michael T. Brady,
- Carrie L. Byington,
- H. Dele Davies,
- Kathryn M. Edwards,
- Mary Anne Jackson,
- Yvonne A. Maldonado
- ,
- Centers for Disease Control and Prevention,
- National Vaccine Program Office,
- National Institutes of Health, Bethesda,
- United States Food and Drug Administration,
- Canadian Pediatric Society
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Since the last policy statement from the American Academy of Pediatrics (AAP) concerning meningococcal vaccine was published in 2011, 2 meningococcal conjugate vaccines have been licensed for use in infants (Hib- MenCY-TT and MenACWY-CRM). The Centers for Disease Control and Prevention (CDC) has published new recommendations, "Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices," which have been endorsed by the AAP. However, the CDC recommendations were published before licensure of MenACWYCRM for infant use. This policy statement updates the AAP recommendations for use of meningococcal vaccines in children and adolescents. A more comprehensive review of background and technical information can be found in the CDC publication.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 400-403 (4 pages)Journal (Volume, Issue Number)
Pediatrics (Volume 134, Issue 2)Publication milestones
- Published - 08/01/2014
Publication status
ISSN
0031-4005Publication IDs
- Scopus: 84905246933
- PubMed: 25070306
